French real estate investment trust Gecimed has said that it will carry out a EUR 100 mln capital increase in order to finance various projects and reduce debt. Shareholders will receive a proposal allowing for their preferential subscription rights to be maintained, following approval of a prospectus by the French securities regulator (AMF), the company said in a press release.
French real estate investment trust Gecimed has said that it will carry out a EUR 100 mln capital increase in order to finance various projects and reduce debt. Shareholders will receive a proposal allowing for their preferential subscription rights to be maintained, following approval of a prospectus by the French securities regulator (AMF), the company said in a press release.
Gecimed also announced that Michel Gay has stepped down as director, with immediate effect. Patrick Arrosteguy will replace him for the period left to run on his predecessor's term of office.
Gecimed is a French SIIC (Société d'Investissement Immobilier Cotée) listed on Euronext Paris. It is the first property management company dedicated exclusively to medical real estate. At end-2008, Gecimed' s portfolio included 34 assets in operation (clinics, hospitals and housing for dependent elderly people) representing 4,326 beds.
